The year 2025 has brought new waves of discussion in U.S. healthcare. With major CDC leadership changes under way, vaccine recommendations and drug policies are once again under scrutiny. Among the most controversial names resurfacing is Ivermectin, a drug that continues to divide the medical community and ignite passionate political debate. This article explores the latest...